This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Identify the Dividend Aristocrats ETF with the lowest fees and understand how fee selection affects long-term performance.
27,609 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
A regional Amazon-like player in LATAM sits near its 52-week low. This article breaks down why MercadoLibre stands ou...
Equity Union Real Estate leverages an agent-first model to propel 2025 loan production, earning recognition as a 2026...
XRP sees a rapid surge in on-chain wallet creation and rising derivatives activity, signaling potential shifts in tra...
Archer Aviation is racing toward FAA certification, but does that milestone alone justify buying its stock? This guid...
Drew Barrymore’s 280-year-old Westchester weekend retreat has secured a buyer, after listing for $4.99 million. The d...
XRP remains under scrutiny as 2026 unfolds, with faster settlement times and evolving regulation shaping its appeal. ...
Florida moves to curb risky AI use, setting the stage for OpenAI’s next legal battle. The actions could alter how inv...
SMCI and Gorilla Technology stock fell sharply after a $2 billion India AI infrastructure deal. Investors are weighin...
SpaceX's plan to go public is one of a kind. This article breaks down what it could mean for investors, from the loft...
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
A researcher from Apex Crypto argues XRP’s flat price path reflects more than market dynamics, pointing to Citibank d...